521 related articles for article (PubMed ID: 24332516)
21. Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion.
Sterry W; Ruzicka T; Herrera E; Takwale A; Bichel J; Andres K; Ding L; Thissen MR
Br J Dermatol; 2002 Dec; 147(6):1227-36. PubMed ID: 12452875
[TBL] [Abstract][Full Text] [Related]
22. [Alternative to surgery in basal cell carcinoma in the elderly population: imiquimod 5% cream].
Arias Santiago SA; Ruiz Villaverde R; Burkhardt Pérez P; Naranjo Sintes R
Rev Esp Geriatr Gerontol; 2009; 44(2):94-7. PubMed ID: 19285364
[TBL] [Abstract][Full Text] [Related]
23. A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma.
Eigentler TK; Kamin A; Weide BM; Breuninger H; Caroli UM; Möhrle M; Radny P; Garbe C
J Am Acad Dermatol; 2007 Oct; 57(4):616-21. PubMed ID: 17610993
[TBL] [Abstract][Full Text] [Related]
24. Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular nasal basal cell carcinomas before Mohs micrographic surgery: a randomized, double blind, vehicle-controlled study.
Butler DF; Parekh PK; Lenis A
Dermatol Surg; 2009 Jan; 35(1):24-9. PubMed ID: 19018814
[TBL] [Abstract][Full Text] [Related]
25. Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.
Richel O; de Vries HJ; van Noesel CJ; Dijkgraaf MG; Prins JM
Lancet Oncol; 2013 Apr; 14(4):346-53. PubMed ID: 23499546
[TBL] [Abstract][Full Text] [Related]
26. Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial.
Migden MR; Guminski A; Gutzmer R; Dirix L; Lewis KD; Combemale P; Herd RM; Kudchadkar R; Trefzer U; Gogov S; Pallaud C; Yi T; Mone M; Kaatz M; Loquai C; Stratigos AJ; Schulze HJ; Plummer R; Chang AL; Cornélis F; Lear JT; Sellami D; Dummer R
Lancet Oncol; 2015 Jun; 16(6):716-28. PubMed ID: 25981810
[TBL] [Abstract][Full Text] [Related]
27. Recurrence rate of superficial basal cell carcinoma following successful treatment with imiquimod 5% cream: interim 2-year results from an ongoing 5-year follow-up study in Europe.
Gollnick H; Barona CG; Frank RG; Ruzicka T; Megahed M; Tebbs V; Owens M; Stampone P
Eur J Dermatol; 2005; 15(5):374-81. PubMed ID: 16172048
[TBL] [Abstract][Full Text] [Related]
28. Sustained clearance of superficial basal cell carcinomas treated with imiquimod cream 5%: results of a prospective 5-year study.
Quirk C; Gebauer K; De'Ambrosis B; Slade HB; Meng TC
Cutis; 2010 Jun; 85(6):318-24. PubMed ID: 20666194
[TBL] [Abstract][Full Text] [Related]
29. Topical imiquimod treatment of superficial and nodular basal cell carcinomas in patients affected by basal cell nevus syndrome: a preliminary report.
Micali G; De Pasquale R; Caltabiano R; Impallomeni R; Lacarrubba F
J Dermatolog Treat; 2002 Sep; 13(3):123-7. PubMed ID: 12227875
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens.
Shumack S; Robinson J; Kossard S; Golitz L; Greenway H; Schroeter A; Andres K; Amies M; Owens M
Arch Dermatol; 2002 Sep; 138(9):1165-71. PubMed ID: 12224977
[TBL] [Abstract][Full Text] [Related]
31. The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient.
Kagy MK; Amonette R
Dermatol Surg; 2000 Jun; 26(6):577-8; discussion 578-9. PubMed ID: 10848940
[TBL] [Abstract][Full Text] [Related]
32. Imiquimod 5% cream for the treatment of periocular Basal cell carcinoma.
Carneiro RC; de Macedo EM; Matayoshi S
Ophthalmic Plast Reconstr Surg; 2010; 26(2):100-2. PubMed ID: 20305508
[TBL] [Abstract][Full Text] [Related]
33. Imiquimod and lymphatic field clearance: a new hypothesis based on a remote immune action on skin cancer.
Akkilic-Materna M; Massone C; Komericki P
Acta Derm Venereol; 2011 Jun; 91(4):432-5. PubMed ID: 21547348
[TBL] [Abstract][Full Text] [Related]
34. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies.
Geisse J; Caro I; Lindholm J; Golitz L; Stampone P; Owens M
J Am Acad Dermatol; 2004 May; 50(5):722-33. PubMed ID: 15097956
[TBL] [Abstract][Full Text] [Related]
35. Imiquimod: new indication. Basal cell carcinoma: inferior to other treatments.
Prescrire Int; 2006 Aug; 15(84):130-1. PubMed ID: 16989024
[TBL] [Abstract][Full Text] [Related]
36. Letter: Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular basal cell carcinomas before Mohs micrographic surgery: a randomized, double-blind, vehicle-controlled study.
Moehrle M; Breuninger H; Schippert W; Häfner HM
Dermatol Surg; 2010 Mar; 36(3):428-30. PubMed ID: 20402949
[No Abstract] [Full Text] [Related]
37. Multiple basal cell carcinomas in xeroderma pigmentosum treated with imiquimod 5% cream.
Malhotra AK; Gupta S; Khaitan BK; Verma KK
Pediatr Dermatol; 2008; 25(4):488-91. PubMed ID: 18789101
[TBL] [Abstract][Full Text] [Related]
38. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study.
Geisse JK; Rich P; Pandya A; Gross K; Andres K; Ginkel A; Owens M
J Am Acad Dermatol; 2002 Sep; 47(3):390-8. PubMed ID: 12196749
[TBL] [Abstract][Full Text] [Related]
39. Multiple superficial basal cell carcinomata--topical imiquimod versus curette and cryotherapy.
Dixon AJ
Aust Fam Physician; 2005; 34(1-2):49-52. PubMed ID: 15727358
[TBL] [Abstract][Full Text] [Related]
40. Treatment of cutaneous tumors with topical 5% imiquimod cream.
Alessi SS; Sanches JA; Oliveira WR; Messina MC; Pimentel ER; Festa Neto C
Clinics (Sao Paulo); 2009; 64(10):961-6. PubMed ID: 19841702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
